Prospective Belgian study of neurodegenerative and vascular dementia:: APOE genotype effects

被引:103
作者
Engelborghs, S
Dermaut, B
Goeman, J
Saerens, J
Mariën, P
Pickut, BA
Van den Broeck, M
Serneels, S
Cruts, M
Van Broeckhoven, C
De Deyn, PP
机构
[1] Univ Instelling Antwerp, Born Bunge Fdn, Dept Biomed Sci, Lab Neurochem & Behav, B-2610 Antwerp, Belgium
[2] Middelheim Hosp, Dept Neurol, Antwerp, Belgium
[3] Middelheim Hosp, Memory Clin, Antwerp, Belgium
[4] Univ Instelling Antwerp, Born Bunge Fdn, Dept Mol Genet, B-2610 Antwerp, Belgium
关键词
D O I
10.1136/jnnp.74.8.1148
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The authors conducted a prospective study of neurodegenerative and vascular dementia in Belgium. Strict diagnostic inclusion criteria were used to include well defined patients and controls. The results of apolipoprotein E (APOE) genotype effect on risk and clinical characteristics are presented. Methods: APOE genotyping was performed in patients with probable Alzheimer's disease (AD) (n=504), frontotemporal dementia (FTD) (n=47), vascular dementia (VaD) (n=152), mixed dementia (n=132), mild cognitive impairment (MCI) (n=44), Parkinson's disease (PD) (n=30), dementia with Lewy bodies (DLB) (n=17), and multisystem atrophy (MSA)/progressive supranuclear palsy (PSP) (n=12). Results: The APOE allele frequencies of this Belgian control population (epsilon2: 6.9%; epsilon3: 76.2%; epsilon4: 16.9%) did not differ from those reported for other white populations. AD, MCI, and mixed dementia patients had higher APOE epsilon4 (32.9%, 38.6%, and 28.4% respectively) and lower APOE epsilon3 (62.2%, 53.4%, and 66.3%) frequencies compared with controls, whereas only AD and mixed dementia patients had lower APOE epsilon2 frequencies (4.9% and 5.3%). Apart from a borderline significant different distribution of APOE allele frequencies in VaD patients compared with controls, no other differences were detected. The influence of APOE epsilon4 on clinical features of dementia was limited to lower age at onset in AD patients and a less pronounced negative correlation between age at onset and number of epsilon4 alleles in MCI and mixed dementia patients. Conclusions: This study confirmed the risk association between APOE epsilon4 and AD. The observation that APOE epsilon4 is associated with mixed dementia reflected the role of AD in the aetiopathogenesis of this condition. Although MCI is an aetiologically heterogeneous syndrome, the increased APOE epsilon4 frequencies indicated that a large proportion of the MCI patients included in the study might be predisposed to develop AD.
引用
收藏
页码:1148 / 1151
页数:4
相关论文
共 23 条
  • [1] Burlinson S, 1998, INT J GERIATR PSYCH, V13, P177, DOI 10.1002/(SICI)1099-1166(199803)13:3<177::AID-GPS758>3.0.CO
  • [2] 2-M
  • [3] ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia
    Chapman, J
    Wang, NS
    Treves, TA
    Korczyn, AD
    Bornstein, NM
    [J]. STROKE, 1998, 29 (07) : 1401 - 1404
  • [4] Accelerated decline in apolipoprotein E-ε4 homozygotes with Alzheimer's disease
    Craft, S
    Teri, L
    Edland, SD
    Kukull, WA
    Schellenberg, G
    McCormick, WC
    Bowen, JD
    Larson, EB
    [J]. NEUROLOGY, 1998, 51 (01) : 149 - 153
  • [5] Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E ε4 frequency, but no tau gene mutations
    Fabre, SF
    Forsell, C
    Viitanen, M
    Sjögren, M
    Wallin, A
    Blennow, K
    Blomberg, M
    Andersen, C
    Wahlund, LO
    Lannfelt, L
    [J]. EXPERIMENTAL NEUROLOGY, 2001, 168 (02) : 413 - 418
  • [6] APOLIPOPROTEIN E4 ALLELE AND COGNITIVE DECLINE IN ELDERLY MEN
    FESKENS, EJM
    HAVEKES, LM
    KALMIJN, S
    DEKNIJFF, P
    LAUNER, LJ
    KROMHOUT, D
    [J]. BRITISH MEDICAL JOURNAL, 1994, 309 (6963) : 1202 - 1206
  • [7] MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN
    FOLSTEIN, MF
    FOLSTEIN, SE
    MCHUGH, PR
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) : 189 - 198
  • [8] The apolipoprotein E ε4 allele is not a significant risk factor for frontotemporal dementia
    Geschwind, D
    Karrim, J
    Nelson, SF
    Miller, B
    [J]. ANNALS OF NEUROLOGY, 1998, 44 (01) : 134 - 138
  • [9] Apolipoprotein E and Alzheimer disease
    Growdon, JH
    [J]. ARCHIVES OF NEUROLOGY, 1998, 55 (08) : 1053 - 1054
  • [10] APOE and the risk of PD with or without dementia in a population-based study
    Harhangi, BS
    de Rijk, MC
    van Duijn, CM
    Van Broeckhoven, C
    Hofman, A
    Breteler, MMB
    [J]. NEUROLOGY, 2000, 54 (06) : 1272 - 1276